Women ages40+ shouldhave a clinicalbreast examat least yearlyBilateralProphylacticMastectomyPrecisionMedicineWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.OvarianSuppressionHormoneReplacementTherapyProgestinPagetDiseaseKappaEpsilonPalbociclibDefinitiveSurgeryMegestrolAcetateMRICalcificationsHormoneReceptorStatusmTORInhibitorsAyurveda1 in 8womenSelf-examinationMastalgiaDown-StagingEstradiolAromataseInhibitorsEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearExcisionalBiopsyAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenBenignPhyllodesTumorBreastCancerGeneticCounselingAbsoluteRiskTyrosine-KinaseInhibitorImmunotherapyAlopeciaSclerosingAdenosisChemotherapyGenomicTestingBI-RADSRelapseEvidencesuggests thatphysical activitymay reduce therisk of breastcancersHER-2PI3KinaseInhibitorsRaloxifeneCapecitabinePaclitaxelCyclophosphamideCytotoxicInvasiveBreastCancerTamoxifenApoptosisBevacizumabGeneticPredisposition5-FluorouracilStagingAntibodyTherapyTripleNegativeBreastCancerNeoplasmAnastrozoleDisease-FreeSurvivalRateAdjuvantTherapyPathologicResponseFISHER+BrachytherapyIn-situCarcinomaLumpGailModelTumorGradeLapatinibHerceptinAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerEGFR(epidermalgrowth factorreceptor)MastitisMetastaticBreastCancerMastectomyRadiotherapyPalpationFamilyHistoryGeneMutationFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.AngiogenesisDoxorubicinlatissimusflapChemopreventionRADBiopsyNodeNegativeAdvocacyMetastasisFlowCytometryACChemotherapyAntiemeticCheckpointInhibitorLiquidBiopsyFibroadenomaCytostaticEndometrialCancerCo-survivorMorpheaGuaranteedRenewableInsuranceMethotrexateNeoadjuvantTherapyGermlineMutationKi-67RateDoseDenseTherapyMolecularBreastImagingCachexiaLymphoscintigraphyOligometastasesBRCAGeneMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltCAMPARPInhibitorsMastodyniaAxillarySamplingPhyllodesTumorSERMOophorectomyBOCADocetaxelECOGScoreLymphNodeStatusNodePositiveCystMultimodalityTherapyDiabeticMastopathyCMFChemotherapyLCISTriplePositiveBreastCancerAdenocarcinomaER-MultifocalTumorsBreastTomosynthesisEstrogenCDK4/6InhibitorsLumpectomyIntraductalPapillomaBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55DimplingWomen ages40+ shouldhave a clinicalbreast examat least yearlyBilateralProphylacticMastectomyPrecisionMedicineWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.OvarianSuppressionHormoneReplacementTherapyProgestinPagetDiseaseKappaEpsilonPalbociclibDefinitiveSurgeryMegestrolAcetateMRICalcificationsHormoneReceptorStatusmTORInhibitorsAyurveda1 in 8womenSelf-examinationMastalgiaDown-StagingEstradiolAromataseInhibitorsEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearExcisionalBiopsyAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenBenignPhyllodesTumorBreastCancerGeneticCounselingAbsoluteRiskTyrosine-KinaseInhibitorImmunotherapyAlopeciaSclerosingAdenosisChemotherapyGenomicTestingBI-RADSRelapseEvidencesuggests thatphysical activitymay reduce therisk of breastcancersHER-2PI3KinaseInhibitorsRaloxifeneCapecitabinePaclitaxelCyclophosphamideCytotoxicInvasiveBreastCancerTamoxifenApoptosisBevacizumabGeneticPredisposition5-FluorouracilStagingAntibodyTherapyTripleNegativeBreastCancerNeoplasmAnastrozoleDisease-FreeSurvivalRateAdjuvantTherapyPathologicResponseFISHER+BrachytherapyIn-situCarcinomaLumpGailModelTumorGradeLapatinibHerceptinAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerEGFR(epidermalgrowth factorreceptor)MastitisMetastaticBreastCancerMastectomyRadiotherapyPalpationFamilyHistoryGeneMutationFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.AngiogenesisDoxorubicinlatissimusflapChemopreventionRADBiopsyNodeNegativeAdvocacyMetastasisFlowCytometryACChemotherapyAntiemeticCheckpointInhibitorLiquidBiopsyFibroadenomaCytostaticEndometrialCancerCo-survivorMorpheaGuaranteedRenewableInsuranceMethotrexateNeoadjuvantTherapyGermlineMutationKi-67RateDoseDenseTherapyMolecularBreastImagingCachexiaLymphoscintigraphyOligometastasesBRCAGeneMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltCAMPARPInhibitorsMastodyniaAxillarySamplingPhyllodesTumorSERMOophorectomyBOCADocetaxelECOGScoreLymphNodeStatusNodePositiveCystMultimodalityTherapyDiabeticMastopathyCMFChemotherapyLCISTriplePositiveBreastCancerAdenocarcinomaER-MultifocalTumorsBreastTomosynthesisEstrogenCDK4/6InhibitorsLumpectomyIntraductalPapillomaBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55Dimpling

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
  1. Women ages 40+ should have a clinical breast exam at least yearly
  2. Bilateral Prophylactic Mastectomy
  3. Precision Medicine
  4. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  5. Ovarian Suppression
  6. Hormone Replacement Therapy
  7. Progestin
  8. Paget Disease
  9. Kappa Epsilon
  10. Palbociclib
  11. Definitive Surgery
  12. Megestrol Acetate
  13. MRI
  14. Calcifications
  15. Hormone Receptor Status
  16. mTOR Inhibitors
  17. Ayurveda
  18. 1 in 8 women
  19. Self-examination
  20. Mastalgia
  21. Down-Staging
  22. Estradiol
  23. Aromatase Inhibitors
  24. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
  25. Excisional Biopsy
  26. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
  27. Benign Phyllodes Tumor
  28. Breast Cancer
  29. Genetic Counseling
  30. Absolute Risk
  31. Tyrosine-Kinase Inhibitor
  32. Immunotherapy
  33. Alopecia
  34. Sclerosing Adenosis
  35. Chemotherapy
  36. Genomic Testing
  37. BI-RADS
  38. Relapse
  39. Evidence suggests that physical activity may reduce the risk of breast cancers
  40. HER-2
  41. PI3 Kinase Inhibitors
  42. Raloxifene
  43. Capecitabine
  44. Paclitaxel
  45. Cyclophosphamide
  46. Cytotoxic
  47. Invasive Breast Cancer
  48. Tamoxifen
  49. Apoptosis
  50. Bevacizumab
  51. Genetic Predisposition
  52. 5-Fluorouracil
  53. Staging
  54. Antibody Therapy
  55. Triple Negative Breast Cancer
  56. Neoplasm
  57. Anastrozole
  58. Disease-Free Survival Rate
  59. Adjuvant Therapy
  60. Pathologic Response
  61. FISH
  62. ER+
  63. Brachytherapy
  64. In-situ Carcinoma
  65. Lump
  66. Gail Model
  67. Tumor Grade
  68. Lapatinib
  69. Herceptin
  70. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  71. EGFR (epidermal growth factor receptor)
  72. Mastitis
  73. Metastatic Breast Cancer
  74. Mastectomy
  75. Radiotherapy
  76. Palpation
  77. Family History
  78. Gene Mutation
  79. For every 1,000 screening mammograms performed, about five breast cancers are detected.
  80. Angiogenesis
  81. Doxorubicin
  82. latissimus flap
  83. Chemoprevention
  84. RAD
  85. Biopsy
  86. Node Negative
  87. Advocacy
  88. Metastasis
  89. Flow Cytometry
  90. AC Chemotherapy
  91. Antiemetic
  92. Checkpoint Inhibitor
  93. Liquid Biopsy
  94. Fibroadenoma
  95. Cytostatic
  96. Endometrial Cancer
  97. Co-survivor
  98. Morphea
  99. Guaranteed Renewable Insurance
  100. Methotrexate
  101. Neoadjuvant Therapy
  102. Germline Mutation
  103. Ki-67 Rate
  104. Dose Dense Therapy
  105. Molecular Breast Imaging
  106. Cachexia
  107. Lymphoscintigraphy
  108. Oligometastases
  109. BRCA Gene
  110. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt
  111. CAM
  112. PARP Inhibitors
  113. Mastodynia
  114. Axillary Sampling
  115. Phyllodes Tumor
  116. SERM
  117. Oophorectomy
  118. BOCA
  119. Docetaxel
  120. ECOG Score
  121. Lymph Node Status
  122. Node Positive
  123. Cyst
  124. Multimodality Therapy
  125. Diabetic Mastopathy
  126. CMF Chemotherapy
  127. LCIS
  128. Triple Positive Breast Cancer
  129. Adenocarcinoma
  130. ER-
  131. Multifocal Tumors
  132. Breast Tomosynthesis
  133. Estrogen
  134. CDK4/6 Inhibitors
  135. Lumpectomy
  136. Intraductal Papilloma
  137. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  138. Dimpling